Asset Optimization & Commercialization

Photo of bridge at night with light trails from cars on it with city in the distance

There is no “one size fits all” approach to creating the right development and commercial strategy for your platform and asset. Defining the opportunity, differentiating your platform and asset, and demonstrating value beyond standard of care is vital and has become more challenging in an increasingly complex and competitive context. Lumanity does more than guide your development and commercial strategy; we uncover real world insights that go beyond the ‘what’ to understand the ‘why’, providing pharmaceutical and biotech companies with robust strategies they can be confident in across the lifecycle: from innovation through development to commercialization and beyond.

We Can Help You:

We can help you evaluate potential opportunities through developing a deep understanding of the current and anticipated state of scientific, competitive, and commercial environments within specific disease areas. Using bespoke-designed research with key stakeholders to ground your decision making, we can guide your acquisition and commercial development strategies. Our teams can help with:

Scientific, market, and landscape assessments
Horizon scanning
Competitive analysis
KOL research
Analogue intelligence
Scenario planning
Opportunity assessment, target product profile and value development
Early asset development and commercial strategy

We utilize a range of research techniques to guide these investment decisions, including TPP assessment, conjoint analysis, and key drivers analysis. We work with your teams to utilize the optimal research design for your project needs.

Whitepaper Jun 28, 2023

Scenario-based Strategy in Tumultuous Times: How pharma executives can conquer uncertainty

Learn more about the key trends driving industry uncertainty and how pharma companies can best adapt their strategies to outcompete and thrive.

Our experience, expertise and approaches ground your scientific advances in a real world understanding of key stakeholder needs and behaviors. We help ensure that the perspective and voice of investors, strategic partners, patients, caregivers, HCPs, and payers is at the foundation of and compels your strategy. We use behavioral science techniques within both the design of our research, and the interpretation of the data uncovered, to gain an in-depth understanding of what drives behaviors, and how to disrupt and change them to lead to improved outcomes. Our teams can support you with:

Company analogues assessment and scenario modeling
Corporate and partnering strategy development
Pipeline build—opportunity search and evaluation
Target product profile and value development
Valuation and forecasting
Deal benchmarking and modeling
KOL (Investor, Partner, Physician and Payer) Assessment
Patient unmet needs assessments
Input to clinical trial design, including patient-related outcomes
Understanding the patient journey and treatment pathways, including our web-based mapping tool, Pathway
Social media listening as a tool for understanding your stakeholders
Qualitative research to assess drivers and barriers of behavior
Qualitative and quantitative approaches to patient and HCP segmentation
HCP omni-channel tracking with Engage
Awareness and usage research

Whitepaper Jul 5, 2023

A Practical Guide to Segmentation: What, who, why, and how?

This white paper delves deeper into the practicalities and nuances of stakeholder segmentation, allowing you to gain valuable insights that will empower you to determine and implement the right segmentation approach for your asset, brand, or portfolio.

By ensuring insight-driven development, commercial and corporate strategies, we help you make choices that maximize opportunities, mitigate risk and drive innovation, differentiation, and value. We can help with the full range of development and commercial strategic needs, including:

Indication prioritization and sequencing
Valuation and forecasting
Deal benchmarking and modeling
Corporate and partnering strategy; search and evaluation
Platform, asset, and brand strategy
Portfolio and therapeutic area strategy
Product profile optimization
Competitor planning and response
Positioning platform development and testing
Communication platform optimization
Omnichannel strategy
Go-to-market strategy
Commercialization strategy and launch planning
Effectiveness and brand performance tracking

Whitepaper Sep 11, 2023

Before You Start the Strategic Planning Cycle: 5 essential things to streamline your approach

Our Impact

25+

With extensive experience across multiple therapy areas and geographies, we’ve been developing, co-creating, and pressure testing brand and pharmaceutical launch strategies across the lifecycle for 25+ years

We support an average of 30 brand launches per year, including a large concentration of those in rare disease, advanced therapeutics, immuno-oncology, and cardiology

60+

We work with a network of partners across 60 markets around the world

Our Work

Case Study May 30, 2023

Developing an Above Therapy Area Proposition and Communication Framework

Read about a client who utilized Lumanity's brand and portfolio strategy expertise to create a compelling above-therapy area proposition and communication framework to demonstrate their leadership in immunology.